Laugh Loud, Laugh Hard, Live Long
Mirth as medicine was first prescribed in the 14th century when Henri de Mondeville — the “Father of French surgery” — asked hospital visitors to give joie de vivre to his patients via jokes.
Tagged: stem cells
Feeling Great Forever
I just got back from a short trip to Mexico where I went for the express purpose of having a few grams of placental tissue transplanted beneath the skin of my lower abdomen.
Targeting Cancer Cells with Nanoparticles
Cancer is the number two cause of death in the United States, killing over 550,000 people annually according to the American Cancer Society’s 2009 Cancer Statistics report.
Wake from Cryonics
The laws are complicated, and not stacked in your favor, but if done carefully it’s possible to leave a huge death benefit payoff from your life insurance policy to your cryonically-preserved self.
Potato blight’s gene weaponry revealed
The blight that caused the infamous Irish potato famine of the 1840s has yielded its genetic secrets. An international team has sequenced the DNA of the microorganism that was to blame.
Tweaking Your Neurons
"Four shots in my Americano, please. I’ve got a presentation due tomorrow at 9:00 a.m. and I haven’t started it yet. I’ll probably be up all night.”
This is Your Brain on Neurotechnology
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin’s Press, July 2009). Neurotechnology is the emerging science of brain imaging and other new tools for both understanding and influencing our brains.
Changes in net flow of ocean heat correlate with past climate anomalies
Physicists at the University of Rochester have combed through data from satellites and ocean buoys and found evidence that in the last 50 years, the net flow of heat into and out of the oceans has changed direction three times.
Phase 3 Alzheimer’s drug increases toxic beta amyloid in the brain — but still provides benefits
New insights into how a Phase III Alzheimer’s drug might work were among the advances in potential therapies targeting two abnormal brain proteins – beta amyloid and phosphorylated tau – that were reported today at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.